4266
D. S. Dodd, R. L. Martinez / Tetrahedron Letters 45 (2004) 4265–4267
method was found to be extremely versatile and can be
applied to a diverse range of b-ketoamides and mono-
substituted hydrazines.
when reacted with phenylhydrazine, gave product 1a in
95% yield, whereas substrate 2b (R4 ¼ Ph) reacted with
phenylhydrazine to give product 1c in only 65% yield.
The initial transient hydrazone 3, formed from the
substrates where R4 is Ph, took longer to cyclize and
usually gave more of the pyrazoloneside product 4.7d;e
The results of a representative study examining the
reactivity of various secondary and tertiary amides
(Table 1) with phenylhydrazine and benzylhydrazine are
reported in Table 2.
In general, phenyl hydrazine gave slightly better
yields with C-2 (R3) unsubstituted b-ketoamides (2a–f)
than did benzylhydrazine. Whereas, benzylhydrazine
appeared to give slightly better yields with C-2 substi-
tuted substrates (2g–m) than did phenylhydrazine.
Furthermore, it was noticed that the reaction with
benzylhydrazine proceeded faster than with phenyl-
hydrazine.
In all cases the C-2 unsubstituted b-ketoamides 2a–f, in
which R3 is H, consistently gave higher yields (respective
products 1a–l, Table 2) than their counterparts 2g–m,
where R3 is Me or Ph (products 1m–u, Table 2). Though
the number of examples is limited, substrate 2g, in which
R3 is Me, gave significantly better yields (products 1o
and 1p) than substrate 2m, where R3 is a Ph8 (product
1m and 1n, Table 2). As a general rule b-ketoamides
where R4 is Me (alkyl) reacted much faster and generally
gave higher yields than substrates in which R4 is Ph
(aryl).7c As an example, b-ketoamide 2a (R4 ¼ Me),
As for the substituents on the amide nitrogen or sec-
ondary versus tertiary amides 2, the effect is not so clear
cut and no trends were apparent. N-Aryl and N-alkyl
substituents were tolerated equally well and the substi-
tution pattern and the nature of the groups at C-2 (R3)
and C-4 (R4) on the b-ketoamides appear to determine
the fate of the reaction.
Table 1. The b-ketoamides 2 used in the study5
Compound
R1
R2
R3
R4
In summary, a mild one-pot procedure for the prepa-
ration of 5-N-mono- or 5-N,N-disubstituted-aminopyr-
azoles has been presented.9 This protocol negates the
need for pregeneration of b-ketothioamides as described
previously1b;c;d and is thus easily adaptable for auto-
mated parallel synthesis. The versatility and mild nature
of this method has also been exploited for the solid-
2a
2b
2c
2d
2e
2f
Et
Et
Et
Et
H
H
Me
Ph
H
Bn
Bn
Ph
Ph
Et
H
Me
Ph
H
H
H
H
Me
Ph
H
H
2g
2h
2i
Et
Et
H
Me
Me
Me
Me
Me
Me
Ph
Me
Ph
Et
supported
amino)pyrazoles and will be reported in due course.
synthesis
of
5-(N-mono-substituted-
Bn
Bn
Ph
Ph
Et
Me
Ph
2j
H
2k
2l
Me
Me
Et
Me
Ph
2m
Me
Acknowledgements
The authors would like to acknowledge Sarah C. Trae-
ger of Discovery Analytical Sciences-BMS for her con-
tributions in establishing the regiochemistry of the
5-aminopyrazoles and Dr. Cullen Cavallaro for a thor-
ough review of this manuscript.
Table 2. Yields of 5-aminopyrazoles 1
Compound R1
R2
R3
R4
R5
Yield
(%)a;b
1a
1b
1c
1d
1e
1f
Et
Et
Et
Et
Et
Et
H
H
Me
Me
Ph
Ph
Bn
Ph
Bn
Ph
Bn
Ph
Bn
Ph
Ph
Ph
Ph
Ph
Bn
Ph
Bn
Ph
Ph
Ph
Ph
Ph
95
87
65
52
91
87
67
50
95
45
92
40
13
15
55
60
32
55
43
30
26
H
Et
Et
H
H
Ph
Bn
Bn
Bn
Bn
Ph
Ph
Ph
Ph
Et
H
Me
Me
Ph
References and notes
H
H
1g
1h
1I
1j
H
H
1. For some recent reports see: (a) Sakya, S. M.; Rast, B.
Tetrahedron Lett. 2003, 44, 7629; (b) Tang, J.; Shewchuk,
L. M.; Sato, H.; Hasegawa, M.; Washio, Y.; Nishigaki, N.
Bioorg. Med. Chem. Lett. 2003, 13, 2985; (c) Cooper, C. B.;
Helal, C. J.; Sanner, M. A.; Wagner, T. T. PCT WO 02/
18346A1, 2002; (d) Schenone, S.; Bruno, O.; Ranise, A.;
Bondavalli, F.; D’Amico, M.; Filippelli, W.; Falcone, G.;
De Novellis, V. Il Farmaco 1995, 50, 179.
H
H
Ph
H
H
Me
Ph
H
H
1k
1l
Me
Me
Et
Et
Et
Et
Et
H
H
Me
Ph
H
1m
1n
1o
1p
1q
1r
1s
1t
Ph
Ph
Me
Me
Me
Me
Me
Me
Me
Me
Me
Me
Me
Ph
Et
Et
2. (a) Ancel, J. E.; El Kam, L.; Gadras, A.; Grimaud, L.; Jana,
N. K. Tetrahedron Lett. 2002, 43, 8319; (b) Atlan, V.; El
Et
Et
€
Kaım, L.; Grimaud, L.; Jana, N. K.; Majee, A. Synlett
2002, 352; (c) Atlan, V.; Buron, C.; El Kaım, L. Synlett
Bn
Bn
Ph
Ph
Me
Ph
€
H
2000, 489; (d) Palacios, F.; Aparicio, D.; de los Santos, J.
M. Tetrahedron 1996, 52, 4123.
H
Me
Ph
1u
H
~
ꢀ
3. (a) Moreno-Manas, M.; Sebastian, R. M.; Vallribera, A.;
Carini, F. Synthesis 1999, 157; (b) Abdel-Rahman, R. M.;
Seada, M.; Fawzy, M.; El-Baz, I. Pharmazie 1994, 49, 729.
a Purified using reverse phase preparative HPLC.
b Yield averaged from two runs.